Breaking the Cycle of Bacterial Growth and Resistance
An Innovative Biotech Company in Boulder, CO.
Crestone is a Boulder, Colorado based clinical stage biopharmaceutical company developing new drug candidates with entirely novel mechanisms. Our research pipeline includes: C. diff treatment, antibiotic-resistant Gram-positive infection treatments, Tuberculosis treatments, and more.
See our progress
Pipeline
Learn about us
Our Company
Get the latest news
Press Releases
Get to know us
Our Team
Who We Are
Boulder, Colorado-based Crestone, Inc. is a clinical stage biopharmaceutical company focused on inventing and developing novel mechanism of action small molecule drugs for serious bacterial infections. Our pipeline includes antibacterial agents aiming to treat a variety of serious conditions caused by antibacterial-resistant microbes, from C. difficile infection to MRSA, tuberculosis, and more.
Our Pipeline
Our R&D pipeline includes several programs that address areas of significant and growing unmet medical need, such as C. diff infection, all with novel mechanism of action agents.
Knowledge Portal
Complete Overview of Vancomycin-resistant Enterococcus Illnesses
Vancomycin-resistant enterococci (VRE) are Gram-positive bacteria. Vancomycin-resistant enterococci cause...
Keystone Symposia: Antimicrobial Resistance & Microbiome Presentation
Keystone Symposia Presentation Details Poster: Phase 2 Clinical Trial Design for CRS3123, a Novel Narrow-Spectrum Agent in Development to Treat C. difficile Infections
Become a Part of Our Projects
Interested in helping further our research into novel antibacterial agents? We’d be thrilled to have your help, either as an investoror a team member.
Inquiries
Have a question or comment? Follow the link below to contact us about general inquiries.
Careers
Find work in a team-oriented environment at one of the leading Colorado pharma companies.
Investors
If you're interested in becoming an investor to help fund our research and development, contact us today.